Thanks for your assessment. Fyi this Mdgl was values at 2 billion zero revenue company less than a year ago. Currently right around 1 billion. Keep in mind thwre finances according to their 10Q not good either. If you research them a little you will see only a tiny fraction of drug pipeline compared tp CYDY. I imagine their SP sill go up or down significantly they did delay results so it has been downward trend. Just proves many peoples thoughts when thinking of valuations and doing comparisons. CYDY has so many pieces that are worth there own valuation some much more than others. CYDY truly a very Unique stock because majority of small biotechs have i tray of biscuits in the oven, if they are under cooker or over cooked and don’t come out right that company is done with….. cydy has a commercial kitchen trays and trays of different biscuits like a giant bakery in multiple ovens.